⌘K

Login Start Free

Home/Filings/4/0001209191-23-034847

4//SEC Filing

Coleman Mark 4

Accession 0001209191-23-034847

CIK 0001579428other

View on SEC.gov Company Profile

Filed

Jun 5, 8:00 PM ET

Accepted

Jun 6, 6:21 PM ET

Size

5.3 KB

Accession

0001209191-23-034847

Insider Transaction Report

Form 4

Period: 2023-06-02

Axsome Therapeutics, Inc.AXSM

Director

Transactions

Award
Stock Option (Right to Buy)
2023-06-02+5,681→ 5,681 total
Exercise: $74.12From: 2024-06-02Exp: 2033-06-02→ Common Stock (5,681 underlying)

Footnotes (1)

[F1]The option vests in full on the one-year anniversary of the date of grant, June 2, 2024.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Axsome Therapeutics, Inc.

CIK 0001579428

Entity typeother

Related Parties

1

filerCIK 0001658379

Filing Metadata

Form type: 4
Filed: Jun 5, 8:00 PM ET
Accepted: Jun 6, 6:21 PM ET
Size: 5.3 KB

View on SEC.gov